Facebook Twitter Instagram
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Facebook Twitter Instagram
    Pharmacognosy Communications
    • Home
    • About Journal
      • Aim and Scope
      • Editorial Board
      • Indexing Info
      • Contact Us
    • Browse Issues
      • Articles in Press
      • Current Issue
      • Past Issues
    • For Authors
      • Instructions to Authors
      • Article Processing Charges
      • Submit your article
      • Downloads
    Pharmacognosy Communications
    retyeyutreu
    Research Article

    Acute and Chronic Toxicity of Aqueous Extract of Ruta Montana L. in Rodents

    wadmin2By wadmin2March 25, 2013Updated:August 12, 2021No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    Share
    Facebook Twitter LinkedIn WhatsApp Pinterest Email

    Soulef Boussahel1, Assia Belguet1,Khadidja Dehimi1 and Daoud Harzallah2
    1Laboratory of Phytotherapy Applied to Chronic Diseases, Department of Animal Biology and Physiology, Faculty of Natural and Life Sciences, University Ferhat Abbas, Sétif 19000 Algeria.
    2Laboratory of Applied Microbiology, Department of Microbiology, Faculty of Natural and Life Sciences, University Ferhat Abbas, Sétif,19000, Algeria

    Pharmacognosy Communications,2013,3,2,50-57.
    DOI:10.5530/pc.2013.2.11
    Published:March 2013
    Type:Research Article

    ABSTRACT

    The objective of this study was to evaluate the acute and chronic toxicity of aqueous extract of Ruta montana L. in mice and rats. For the acute study, aqueous extract of Ruta montana L. was administered to mice in single doses of 0–12 g/kg given by gavage. General behavior, adverse effects and mortality were determined for up to 14 days. In the chronic study, the extract was administered orally at doses of 0, 100, 300 and 600 mg/kg daily for 90 days to rats. Biochemical and hematological parameters were determined after 30 and 90 days. Enzyme activities were assayed in the plasma samples obtained. AST (GOT), ALT (GPT), cholesterol, triglyceride and glucose. The results showed a decrease in RBC and WBC after one month (sub chronic dose) of treatment (in males 75.48% and 51.47% respectively). However, an increase was registered after 3 months (in males 130% and 171% respectively). This is probably explained by the effect of this plant extract on the erythropoiesis. A decline was observed on plasma enzyme activities in both GOT and GPT on males after one month by 51.67% and 68.6% respectively. A decrease was noticed in both cholesterol and triglyceride levels. Urine analysis was negative for glucose, bilirubin, ketones, proteins, nitrite and leukocytes in the control and treatment groups. There were no significant differences in the body and organ weights between controls and treated animals of both sexes. The histopathological studies have been showed vascular congestion and lesions of interstitial nephrite.

    Keywords: Acute toxicity, Biochemical parameters, Chronic toxicity, Hematological parameters, Ruta montana L., Mountain rue.

    Download PDF
    Share. Facebook Twitter Pinterest LinkedIn Tumblr WhatsApp Email
    About Journal
    About Journal

    Pharmacognosy Communications [Phcog Commn.] is a quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.
    Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
    Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online publication is 45 days.
    Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.

    © 2025 Pharmacognosy Communications. Maintained by Manuscript TechnoMedia LLP.

    Type above and press Enter to search. Press Esc to cancel.

    Scroll Up